Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 2	2024-12-11		NCT04195139

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cooperative Trials Group for Neuro-Oncology	1
University of Sydney	73

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Hospital	Heidelberg	Australia	37
Campbelltown Hospital	Campbelltown	Australia	12
Chris O'Brien Lifehouse	Camperdown	Australia	46
Duke University Medical Center	Durham	United States	505
Epworth Healthcare	Richmond	Australia	13
Flinders Medical Centre	Bedford Park	Australia	72
Gosford Hospital	Gosford	Australia	18
ICON Cancer Centre	South Brisbane	Australia	5
Monash Medical Centre	Clayton	Australia	60
Newcastle Private Hospital	New Lambton Heights	Australia	4
Peter MacCallum Cancer Centre	Melbourne	Australia	149
Port Macquarie Hospital	Port Macquarie	Australia	2
Prince of Wales Hospital	Randwick	Australia	34
Princess Alexandra Hospital	Woolloongabba	Australia	106
Royal Adelaide Hospital	Adelaide	Australia	132
Royal Brisbane and Women's Hospital	Herston	Australia	35
Royal Hobart Hospital	Hobart	Australia	44
Royal North Shore Hospital	Saint Leonards	Australia	30
Sir Charles Gairdner Hospital	Nedlands	Australia	43
Wollongong Hospital	Wollongong	Australia	29

Clinical trials